Boston Scientific Corp

BSX: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
<jZLOCK|^%d<>LOCK|><L!Dw

Boston Scientific: Despite Solid Quarterly Results, Muted Outlook Cause Shares to Oscillate

Boston Scientific reported decent first-quarter results, with 9% organic top-line growth and 6% year-over-year adjusted earnings growth. But management lowered its outlook due to softness in Watchman, a greater-than-expected share loss in electrophysiology, and personnel turnover in urology.

Sponsor Center